| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Clinical Biochemistry (S.S., D.D.H., B.S.-W., F.B., D.K.), Neuropathology (V.H.J.H.), and Neurosurgery (J.S.), University of Bonn, 53105 Bonn, Germany
Address all correspondence and requests for reprints to: Dr. Stephan Steckelbroeck, Institut für Klinische Biochemie, Universität Bonn, Sigmund Freud Strasse 25, D-53105 Bonn, Germany. E-mail: st_steckelbroeck{at}hotmail.com
Local aromatase-mediated conversion of androgens plays an important role in androgen action on the brain. To characterize estrogen formation in the human brain, we measured the microsomal aromatase activity of temporal lobe biopsies and compared it to that of human placenta using a highly sensitive 3H2O assay with [1ß-3H]androstenedione as substrate. Brain tissue was removed neurosurgically from 23 patients with epilepsy. Data of kinetic studies were analyzed with a computer-assisted, nonlinear, curve-fitting method using the Michaelis-Menten plus a nonspecific metabolism model. In contrast to data for placental aromatase activity, that for brain always had to be corrected for nonspecific tritium release. The mean Km values were 22.2 nmol/L in brain and 49.6 nmol/L in placenta. Inhibition experiments with atamestane, an inhibitor of aromatase cytochrome P450, revealed specific, dose-responsive, and competitive inhibition of both brain and placental aromatase activities. Placental aromatase activity was completely suppressible by atamestane, whereas in brain tissue there remained a residue of nonspecific tritium release. Subsequent experiments with cerebral cortex and subcortical white matter specimens of children and adults revealed a significantly higher aromatase activity in cerebral cortex than in subcortical white matter, but no sex or age differences were found.
This article has been cited by other articles:
![]() |
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. B. Saalmann, I. G. Morgan, and M. B. Calford Neurosteroids Involved in Regulating Inhibition in the Inferior Colliculus J Neurophysiol, December 1, 2006; 96(6): 3064 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Azad, S. Pitale, W. E. Barnes, and N. Friedman Testosterone Treatment Enhances Regional Brain Perfusion in Hypogonadal Men J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3064 - 3068. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F.-L. Chiang, Y.-L. Yan, Y. Guiguen, J. Postlethwait, and B.-c. Chung Two Cyp19 (P450 Aromatase) Genes on Duplicated Zebrafish Chromosomes Are Expressed in Ovary or Brain Mol. Biol. Evol., April 1, 2001; 18(4): 542 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Steckelbroeck, M. Watzka, R. Reichelt, V. H. J. Hans, B. Stoffel-Wagner, D. D. Heidrich, J. Schramm, F. Bidlingmaier, and D. Klingmüller Characterization of the 5{{alpha}}-Reductase-3{{alpha}}-Hydroxysteroid Dehydrogenase Complex in the Human Brain J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1324 - 1331. [Abstract] [Full Text] |
||||
![]() |
Y. Reznik, L. Dehennin, C. Coffin, J. Mahoudeau, and P. Leymarie Urinary Nandrolone Metabolites of Endogenous Origin in Man: A Confirmation by Output Regulation under Human Chorionic Gonadotropin Stimulation J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 146 - 150. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |